Jorey Chernett, a 10% owner of Starling Oncology, Inc. (STLN), divested a significant portion of their holdings on November 10, 2026. Chernett sold 2,851,061 shares at a price of $3.99 per share, resulting in a transaction valued at approximately $11.38 million.
This large sale by a major stakeholder comes shortly after Chernett purchased 48,294 shares for $176,273 on November 9, 2026. Insider sales can be driven by various factors, including portfolio diversification, tax obligations, or pre-arranged trading plans, and do not necessarily reflect a negative outlook on the company's future prospects.
The company's stock has experienced other insider transactions recently, including a sale of 298,853 shares by Brad Hively on August 21, 2026, valued at $1.95 million.